The massive market transformation this month that some on Wall Street called a "once in a decade opportunity" might have just been a one-off technical move because of taxes.Marketsread more
The Pentagon will deploy U.S. forces to the Middle East on the heels of the attack on Saudi Arabian oil facilities, United States Secretary of Defense Mark Esper announced...Defenseread more
CNBC did a deep dive through the most recent Wall Street research to find stocks that analysts say are underappreciated.Marketsread more
Shares of MasterCard are up 46% this year, and 1120% since 2011, getting a boost from the strong U.S. consumer.Investingread more
CNBC sat in on an "empathy training" at Amazon PillPack's Somerville offices, which is part of new hire orientation.Technologyread more
Trade with China is the 'big unknown' for the Federal Reserve as it decides how best to support the U.S. economy, says Council on Foreign Relations Director of International...Futures Nowread more
Lobbying experts said the visit is likely an attempt to be in lawmakers' ears as they consider legislation that would impact Facebook.Technologyread more
Yardeni Research's Edward Yardeni believes the U.S. economy is picking up steam.Trading Nationread more
Iran's audacious drone and cruise missile attack on Saudi Arabia's oil producing facilities has provided a critical test yet for the Trump administration's foreign policy. A...Politicsread more
Chinese trade negotiators suddenly canceled a visit to meet U.S. farmers after they wrapped up trade talks in Washington this week.Marketsread more
Amazon's Grand Challenge team, its equivalent of the Google X lab for moonshot technologies, has made its latest high-profile health care hire.
The company has quietly scooped up Taha Kass-Hout, the former U.S. Food and Drug Administration chief health informatics officer, according to a source with knowledge of the hire.
Kass-Hout will serve in a business development role focusing on health care projects. He will work alongside Amazon Grand Challenge chief Babak Parviz, a former director at Google X who joined Amazon in 2014 as a vice president.
Amazon has remained secretive about its health care ambitions, with a few exceptions.
It did announce a collaboration with J.P. Morgan and Berkshire Hathaway to bring down health care costs and improve quality for its own employees. But it hasn't said much about how that will work, or who will run it.
Amazon's Grand Challenge team has also been referred to internally as 1492. Like Google X, it is focused on very big bets that would potentially create a new category for the business. The multi-trillion dollar health sector is a major focus for the group.
Amazon did not immediately return a request for comment.
Kass-Hout left his previous role at Michigan's Trinity Health in May of last year, and hasn't updated his LinkedIn profile since then.
At Trinity, where he served as a senior vice president, his role involved "leadership and oversight over data, analytics and digital health initiatives," according to his profile.
Prior than that, he worked in senior government roles at the Centers for Disease Control and Prevention and the FDA as its first executive focused on health informatics. He's also a Harvard-trained physician.
His expertise is in health information technologies and digital health, as well as in navigating government regulation.
Most interestingly, he describes his mission on LinkedIn as "empowering consumers via sustainable health data ecosystems."
That suggests Amazon might be looking to help consumers get easier access to health records. Both Apple and Alphabet have launched initiatives to help consumers gain access to their medical information, which is currently scattered across various health systems.
It's a big problem — and a big opportunity for technology companies. More than 250,000 people die every year from medical errors, often resulting from a lack of available patient-data on hospital computer systems. Amazon hasn't revealed its own ambitions in this space, but CNBC reported that it's looking at opportunities to push and pull data from legacy electronic medical systems.
Medical experts say that it's also possible that Kass-Hout will help Amazon through various facets of the regulatory process, especially if it brings new health hardware or software to market.
"It's not clear either way, but it does at least give them the option," said Stephen Buck, a former co-founder of GoodRx, which gives consumers a platform for cheaper medicines. Buck did not have any inside knowledge of the hire.
"It's smart of Amazon to bring in people well versed in health care data and how connectivity is vital to improving results," he added.
Amazon has various teams working internally on a wide variety different health projects, some of which may never reach production.
For instance, it has teams focused on bringing its Alexa voice assistant to health care, figuring out whether it can disrupt the drug supply chain, and selling medical supplies to hospitals. Amazon Web Services is working to serve its customers in the health care sector with cloud technology, and has a deal with Cerner to help better use their data to make health predictions about patient populations.
In addition to Kass-Hout, Amazon this year also scooped up Martin Levine, a prominent Seattle-based geriatrician with an expertise in innovative care delivery models.